Canopy Growth completes acquisition of MTL Cannabis; becomes Canada's #1 medical cannabis company by revenue

Canopy Growth Corp

Acquired all MTL shares for ~41.2M CGC shares + C$18.5M cash; 0.32 CGC share + C$0.144 cash per MTL share.
Combined entity claims #1 medical cannabis market share in Canada by revenue (based on internal calculations).
Expected run-rate synergies of ~$10M within 18 months; goal of positive adj. EBITDA in fiscal 2027.
MTL's CEO Mike Perron becomes Canopy's COO; co-founders Richard & Michel Clement as strategic advisors.
MTL shares to be de-listed from CSE on or about March 16, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.